Published on in Vol 15 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/71696, first published .
Addressing Gaps in the Hypertension and Diabetes Care Continuum in Rural Bangladesh Through Digital Technology Supported Decentralized Primary Care: Study Protocol and Baseline Results for a Hybrid Effectiveness-Implementation Trial

Addressing Gaps in the Hypertension and Diabetes Care Continuum in Rural Bangladesh Through Digital Technology Supported Decentralized Primary Care: Study Protocol and Baseline Results for a Hybrid Effectiveness-Implementation Trial

Addressing Gaps in the Hypertension and Diabetes Care Continuum in Rural Bangladesh Through Digital Technology Supported Decentralized Primary Care: Study Protocol and Baseline Results for a Hybrid Effectiveness-Implementation Trial

1Population and Global Health, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore

2Department of Noncommunicable Diseases, Bangladesh University of Health Sciences, Dhaka, Bangladesh

3Department of Epidemiology and Research, National Heart Foundation Hospital and Research Institute, Dhaka, Bangladesh

4Baker Heart and Diabetes Institute, Melbourne, Australia

5Tyree Foundation Institute of Health Engineering, UNSW Sydney, Sydney, Australia

6Sprightly Pte Ltd, Singapore, Singapore

7Google Health, Palo Alto, CA, United States

8Department of Global Health, School of Public Health, Boston University, Boston, MA, United States

9School of Psychology and Public Health, La Trobe University, Melbourne, Australia

10Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom

11Department of Public Health, North South University, Dhaka, Bangladesh

12NCD Epidemiology Research Center, Shiga University of Medical Science, Otsu, Shiga, Japan

13Centre for Non-communicable Diseases and Nutrition, BRAC James P Grant School of Public Health, BRAC University, 65, Bir Uttam AK Khandakar Road, Mohakhali, Dhaka, Bangladesh

14Australian Institute of Family Studies, Melbourne, Australia

15Department of Health Promotion, Education, and Behavior, Arnold School of Public Health, University of South Carolina, Columbia, SC, United States

16BRAC James P Grant School of Public Health, BRAC University, Dhaka, Bangladesh

17Non-Communicable Disease Control, Directorate General of Health Services, Dhaka, Bangladesh

18BRAC Health Programme, BRAC, Dhaka, Bangladesh

Corresponding Author:

Malay Kanti Mridha, PhD


Background: Hypertension and diabetes are very common, interrelated chronic conditions. Awareness, diagnosis, treatment, and control rates of these conditions remain low, and access to quality care—particularly in rural areas—is a persistent challenge in many low- and middle-income countries. Strengthening primary health care, including the use of digital tools, is important to improve management of these chronic conditions.

Objective: This study aims to assess the implementation and effectiveness of a multicomponent, decentralized primary care model in comparison with a digital health–only intervention and usual care in rural Bangladesh.

Methods: The study applies a type 2 hybrid effectiveness-implementation design, using a 3-arm quasi-experimental approach, comprising 2 intervention arms and 1 usual care comparison arm. The study is being conducted across 3 subdistricts in the Dinajpur district, Rangpur division, northern Bangladesh. Primary outcomes include blood pressure and blood glucose control rates, assessed by population-based repeated cross-sectional surveys with independent samples, supplemented by facility-based prospective cohort data. Additionally, a mixed methods process evaluation is being conducted to capture the quantity, fidelity, adaptations, reach, and context of the interventions.

Results: The baseline community survey was conducted between January and March 2024, enrolling 6849 participants distributed across 3 arms: 2262 in usual care, 2287 in the digital-only arm, and 2300 in the multicomponent intervention arm. Participants had a mean age of 55.9 (SD 10.6) years with equal sex distribution (female: 3432/6849, 50.1%). Educational attainment was low, with 39.5% (2704/6849) of participants having no formal schooling and only 12.1% (917/6849) attaining secondary or higher education. The majority (6316/6849, 92.2%) reported being either self-employed or homemakers. The age-standardized baseline blood pressure control rate among all participants with hypertension was 10.2% overall, while the glycemic control rate among those with diabetes was 14.9%. Awareness and treatment rates for hypertension were 35.3% and 23.0%, respectively, compared to 60.7% and 34.5% for diabetes.

Conclusions: The study findings will provide critical evidence on scalable models for decentralized noncommunicable disease care and will have important implications for improving the management of hypertension and diabetes in Bangladesh and similar low-resource settings globally.

Trial Registration: ClinicalTrials.gov NCT06258473; https://clinicaltrials.gov/study/NCT06258473

International Registered Report Identifier (IRRID): DERR1-10.2196/71696

JMIR Res Protoc 2026;15:e71696

doi:10.2196/71696

Keywords



Hypertension is the leading modifiable risk factor for cardiovascular diseases (CVDs) [1,2], affecting approximately 1 in 5 adult women and 1 in 4 adult men globally [3]. Between 1990 and 2019, the number of adults with elevated blood pressure (BP) has doubled from 650 million to 1.3 billion, largely driven by the increasing prevalence in low- and middle-income countries (LMICs) [4]. Diabetes affects 10.5% of adults worldwide, with nearly half of cases undiagnosed [1]. Poorly controlled hypertension and hyperglycemia contribute substantially to complications including heart disease, stroke, chronic kidney disease, and vision loss [1,5], as well as premature mortality [6]. Despite these health risks, the rates of awareness, treatment, and control of hypertension and diabetes remain alarmingly low in LMICs [7-9], where health systems, especially at the primary care level [10], struggle to meet the rising burden of noncommunicable diseases (NCDs) [11-13]. In 2022, the 75th World Health Assembly established the first global coverage targets for diabetes, aiming for 80% diagnosis rates among people with diabetes and 80% glycemic control among diagnosed cases by 2030. According to the World Health Organization (WHO) 2023 Global Report on Hypertension, achieving the 80-80-80 targets could prevent approximately 79 million nonfatal myocardial infarctions and 76 million cardiovascular deaths worldwide [14].

Access to NCD care remains severely constrained in the primary care systems of most LMICs, particularly in rural settings where health facilities often lack capability and capacity for NCD management [15,16]. Once diagnosed, patient retention poses a tremendous challenge for hypertension and diabetes care [17,18]. Studies in LMIC report dropout rates of over 50% of enrolled patients 6 months following treatment initiation [19,20]. Decentralizing care by task shifting (or task sharing) has been shown to be a feasible and acceptable strategy for scaling up antiretroviral therapy for HIV and AIDS care in resource-constrained settings [21-23]. This approach, which involves transferring routine management of stable patients from physician-managed clinics to peripheral facilities staffed by nonphysician health workers, enhances geographic accessibility, reduces patient costs, and enables the primary care system to serve a much larger patient population [21]. Despite these demonstrated benefits and the potential to address health care workforce shortages and improve access to HIV and AIDS care, few studies have evaluated this strategy for NCDs. Several small-scale studies have experimented with this approach [24-26], including the India Hypertension Control Initiative and the integrated tracking, referral, electronic decision support, and care coordination program for the management of hypertension and diabetes in India [22]. However, broader implementation and effectiveness remain understudied, and the impact on awareness and treatment remains largely unknown.

While digital tools for improving hypertension control and diabetes management are increasingly being tested in LMICs, the evidence for their effectiveness is mixed [27-29], and it is unclear whether standalone digital solutions can significantly improve NCD care delivery [30]. In contrast, multicomponent interventions in primary care have been shown to improve treatment outcomes in several large-scale randomized controlled trials [28,31-33]. These interventions typically combine digital tools with health care provider training, task shifting, community health worker (CHW)-led home-based BP monitoring, counseling, and referral. While showing effectiveness as a whole, partitioning the effect of individual intervention components was not possible in these studies. Nevertheless, evaluating the components individually, early evidence from LMICs shows that task shifting, when accompanied by health system restructuring, is a potentially effective strategy for improving access to NCD care [34], and that using CHWs in health programs may be effective in BP and diabetes control [35].

Among emerging digital solutions, the Simple app—developed and maintained by Resolve to Save Lives—has been increasingly used in South Asia and other LMICs [36]. Currently deployed in 7245 public health facilities in Bangladesh, Ethiopia, India, and Sri Lanka, the platform has registered 3.9 million people with hypertension, diabetes, or both conditions [37,38]. The app addresses two critical determinants of treatment success: (1) timely medication titration and (2) therapy adherence and continuity [39]. Its design intentionally limits data collection to essential variables (eg, prescriptions, follow-up visits, and BP or blood glucose [BG] measurements) to optimize usability in busy primary care settings. However, rigorous evaluation of its impact on clinical and behavioral outcomes remains pending [37].

As part of a UK National Institute for Health Research–funded program, we previously conducted a proof-of-concept trial demonstrating the feasibility of a digital tool to support decentralized care for hypertension and diabetes management in rural Bangladesh [26]. Building on these promising findings, we designed a 3-arm hybrid implementation-effectiveness trial to evaluate the impact of the Simple app within a multicomponent intervention framework, addressing critical gaps in understanding both effectiveness in clinical outcomes and implementation challenges. The paper describes the study methods and baseline findings, serving as a reference framework for subsequent publications from the Dinajpur study.


Study Setting and Populations

Bangladesh, an LMIC in South Asia with a total population of 171.5 million, has undergone major demographic and epidemiologic transitions in recent decades, and NCDs now account for approximately 70% of all deaths nationally [40]. The prevalence of hypertension and diabetes among Bangladeshi adults is estimated to be 27.4% and 9.8%, respectively [41,42]. The awareness, treatment, and control rates among people living with these conditions remain alarmingly low [41,42]. Furthermore, tobacco use, insufficient fruit or vegetable intake, and overweight are highly prevalent [43]. Over the past decade, the Government of Bangladesh has tried to implement national multisectoral actions to strengthen NCD care, most notably through the establishment of dedicated NCD care delivery points (known as “NCD Corners”) in subdistrict hospitals (“Upazila health complex” in local language) since 2011. The initiative’s planned decentralization to village-level primary care facilities (community clinics [CCs]) has not materialized [41]. Consequently, access to public NCD services remains severely limited in rural Bangladesh [41]. The Simple app has been progressively implemented across primary NCD care facilities in Bangladesh since 2020. As of current reporting, more than 180 facilities use the platform to manage over 350,000 hypertension and diabetes patients. The app’s integration with the national health management information system enables real-time performance monitoring and feedback for health facilities.

Study Design

This hybrid effectiveness-implementation trial simultaneously evaluates intervention effectiveness and implementation strategies [44], using a 3-arm, quasi-experimental design. The aims of this trial are (1) to evaluate the effectiveness of a multicomponent, decentralized care model for hypertension and diabetes management within the public primary care systems, compared to both usual care and a standalone digital health intervention (Simple app); (2) to examine implementation processes, including explanatory factors influencing intervention effectiveness and barriers to and facilitators of delivery and sustainability; and (3) to undertake an economic evaluation. We hypothesize that compared with usual care, the multicomponent decentralized primary care—supported by the Simple app—will improve all steps along the hypertension and diabetes care continuum. Conversely, we hypothesize that the mobile health intervention alone (Simple app) may improve BP and glycemic control compared with usual care but will have a limited impact on rates of screening, diagnosis, and treatment; multicomponent integrated care will lead to a higher treatment success rate compared to the mobile health intervention alone.

The study is being conducted across 3 subdistricts in the Dinajpur district, Rangpur division, northern Bangladesh (Figure 1 and Table 1). The multicomponent intervention is being implemented in the Chirirbandar subdistrict, while the digital health–only intervention is being implemented in the Parbatipur subdistrict. The Biral subdistrict serves as the reference site. Primary outcomes include BP and glycemic control rates, assessed by population-based repeated cross-sectional surveys with independent samples, supplemented by facility-based prospective cohort data. Additionally, a mixed methods process evaluation is being conducted to capture the quantity, fidelity, adaptations, reach, and context of the interventions. The study duration is 36 months, including an intervention period of 24 months.

Figure 1. Study sites: Dinajpur district, Rangpur division, Bangladesh. Multicomponent interventions are implemented in the Chirirbandar subdistrict, a digital-only intervention is implemented in the Parbatipur subdistrict, and the Biral subdistrict is the usual care arm. CC: community clinic; UHC: Upazila health complex.
Table 1. Population and health facility statistics in study areas.a
CharacteristicsStudy sites
Chirirbanda (multicomponent)Parbatipur (digital health only)Biral (usual care)
Area (square km)312.7395.0353.4
Population, n292,500365,103257,925
 Adults aged 40+ years, %25.625.425.3
 Persons aged 60+ years, %7.37.27.3
 Muslim, %76.385.572.0
 Urban, %3.011.03.5
Unions, n121010
Villages (wards), n141229238
Health facilities, n
 UHCb111
 Community clinics354034
Literacy rate, %52.953.947.3

aData source: 2011 Bangladesh Census, Bangladesh Ministry of Health and Family Welfare facility registry [45,46].

bUHC: Upazila health complex.

Ethical Considerations

This study was approved by the Institutional Review Board of James P Grant School of Public Health, BRAC University (reference number: IRB-16 November-23‐041). Written informed consent was obtained from all participants. Identifying information associated with the study participants will be kept confidential through unique identifying numbers on all paper forms and computer-based files to protect privacy and ensure confidentiality of data being collected. Participants received no compensation for participation.

Interventions

Development of the Interventions

Building on an assessment of hypertension and diabetes management barriers at the patient, provider, and health system levels [47-50], along with evidence from previous intervention studies and the updated UK Medical Research Council (MRC) guidance on developing and evaluating complex interventions [31-33,51], a multicomponent intervention package has been designed to increase access to primary care and to improve care quality and patient retention (Figure 2).

Figure 2. NCD service delivery hierarchy and decentralized care (adapted from Xie et al [26], which is published under Creative Commons Attribution 4.0 International License). CC: community clinic; CHCP: community health care provider; CHW: community health worker; NCD: noncommunicable disease; Tx: treatment; UHC: Upazila health complex.
Multicomponent Decentralized Care
Digital Health for Patient Management

In alignment with the Bangladesh government recommendations, the Simple app is being used in primary care facilities for coordinated hypertension and diabetes management. The app supports prescription and continuity of care through unique patient IDs and enables functions including: (1) monitoring patient longitudinal BP and BG changes, prescription history, and prompting titration when indicated; (2) flagging overdue patients for action; and (3) generating performance reports on indicators such as patient enrollment and BP and BG control rates. A dedicated project assistant supports health workers with data entry and follow-up with overdue patients.

Decentralization With Task Sharing

Supported by the subdistrict NCD corner, 15 CCs were equipped to conduct screening, follow-ups, and medication refills. Implementation includes several core components: (1) providing regular trainings (every 6 months) for health care providers from the subdistrict NCD corner and CCs on team-based NCD care, (2) equipping CCs for routine care, and (3) providing regular supportive supervision by health officials. CCs received medical devices, Android tablets for record keeping, and essential medications.

Involvement of Community Health Workers

The intervention incorporates hypertension and diabetes management into community-based care through trained CHWs, leveraging evidence from successful LMIC programs [31-33,51-54]. CHWs perform 4 core functions: community screening and case identification, lifestyle counseling and health education, referral coordination, and patient follow-up. Capacity building includes an initial 6-day training conducted in June 2024, supplemented by biannual refresher trainings.

Supportive Monitoring and Supervision and Team-Based Care

The intervention incorporates a multitiered supportive supervision system to ensure quality service delivery. At the subdistrict level, NCD corners receive regular oversight from senior health administrators and medical professionals who address clinical management challenges, medication supply issues, and operational barriers. These supervisory visits are data-driven, using performance metrics generated by the Simple app dashboard to identify priority areas for improvement.

A cascading supervision framework extends to CCs, where subdistrict health officials conduct routine monitoring visits. Community health care providers (CHCPs) similarly provide ongoing supervision to CHWs in their catchment areas. To strengthen health system coordination, monthly meetings convene providers across levels to enhance collaboration, troubleshoot challenges, and optimize care processes.

Throughout the intervention period, dedicated technical support teams maintain system functionality by providing continuous assistance with the Simple app operations and troubleshooting.

Care Continuum Within the Multicomponent Decentralized Care

CHWs conduct targeted health promotion activities to increase NCD and their risk factors, with particular emphasis on encouraging adults aged ≥40 years to undergo screening at CCs. Adults detected with elevated BP or BG at CCs are referred to the subdistrict NCD corner for confirmation and care plan initiation if diagnosed. Patients with known hypertension and diabetes are referred to the NCD Corners for care plan initiation or resumption (for those who discontinued treatment).

At the subdistrict NCD corner, a structured clinical workflow ensures comprehensive patient management. Nurses perform detailed clinical assessments and maintain up-to-date patient records in the digital system. Physicians initiate care plans for new patients and decide if existing patients can be referred to CCs for routine follow-up and management according to the national guidelines (ie, having a controlled status in the three most recent consecutive visits). Prescriptions are guided by the Simple app BP/BG record and prescription history; treatment titration may be done when indicated.

At CC, CHCPs deliver essential NCD services for stable patients, comprising (1) routine clinical monitoring, (2) prescribed medication dispensing, and (3) lifestyle modification counseling. Patients maintaining treatment targets continue community-based management through scheduled follow-ups. For cases demonstrating suboptimal control or presenting with acute symptoms, CHCPs initiate immediate referral to the subdistrict NCD corner for physician evaluation and therapeutic change.

Digital Health–Only Intervention

In the subdistrict (Parbatipur) with digital health–only intervention, initial training on the national protocols for hypertension and diabetes management and the Simple app in the NCD corner was conducted in July 2024. Biannual refresher training will be done throughout the implementation period. A project assistant is hired to help with the Simple app data entry and to follow up with overdue patients. CCs and CHWs are essentially not involved in care provision. Patient pathways remain the same as in usual care.

Usual Care

The usual care subdistrict (Biral) receives biannual training on national protocols for hypertension and diabetes management. Existing usual care is being provided by the subdistrict NCD corner, including screening, treatment initiation, drug refill, and routine follow-up. CCs and CHWs are not involved in NCD care provision. The local government agreed to delay the rollout of the Simple app in the comparison subdistricts until the end of the study to avoid contamination.

Effectiveness and Implementation Outcomes and Assessment

The primary outcome is the proportion of treated patients achieving or maintaining disease control according to national standards and WHO PEN (WHO Package of Essential Noncommunicable Diseases Interventions) protocols, with hypertension control defined as systolic/diastolic BP <140/90 mm Hg and glycemic control as fasting capillary glucose < 7.0 mmol/L or random capillary glucose <11.1 mmol/L. Effectiveness is being assessed primarily using data from repeated community-based surveys. Secondary outcomes of this study include hypertension and diabetes care cascade (ie, percentage of patients ever screened, percentage aware of their condition, and percentage on treatment), changes in health behaviors (eg, smoking cessation among hypertension and diabetes patients, and meeting recommended weekly physical activity level). To complement assessment of population-level changes using repeated community-based surveys, facility-level data will be extracted to evaluate changes in care quality at primary care facilities.

Specific aim 2 is evaluated by using the RE-AIM (reach, effectiveness, adoption, implementation, and maintenance) framework (Table 2) with patient assessments and stakeholder interviews, informed by previous studies [25,55]. Implementation fidelity and process evaluation are guided by the MRC guidelines on process evaluation of complex interventions [56] and the WHO’s NCD Facility-Based Monitoring Guidance [57]. The program theory is depicted in Figure 3. Data sources include training reports, prescription practice captured by the Simple app, facility records, and patient registries. The Simple app captures essential data related to patient background, prescriptions and titration, dates of follow-up visits, and longitudinal BP and BG records. Baseline qualitative data were collected from patients, health care providers, CHWs, and public health managers to inform the evaluation of barriers and enablers of implementing the interventions in the primary care system for improved NCD outcomes. Another round of qualitative data collection will be conducted upon completion of the interventions.

Table 2. Data collection plan for evaluation indicators.
RE-AIMa domains or indicatorsOperational definitionData sourceInstrumentTimeline, at months
Effectiveness
Primary outcomes
Percentage of patients with HTNb who achieved BPc controlBP <140/90 mm HgCommunity surveysOmron HEM-71200, 12, 24
Percentage of patients with DMd who achieved glycemic controlFasting capillary glucose <7.0 mmol/L or random capillary glucose <11.1 mmol/LCommunity surveysAccu-Chek Instant0, 12, 24
Secondary outcomes
Percentage of adults with HTN aware of their conditionEver been told by a health care provider that they have raised BP or HTNCommunity surveysQuestionnaire0, 12, 24
Percentage of adults with DM aware of their conditionEver been told by a health care provider that they have diabetesCommunity surveysQuestionnaire0, 12, 24
Percentage of adults with diagnosed HTN on treatmentCurrently taking medication for HTN, not including herbal or traditional remedyCommunity surveysQuestionnaire0, 12, 24
Percentage of adults with diagnosed DM on treatmentTaking medication for DM, not including herbal or traditional remedyCommunity surveysQuestionnaire0, 12, 24
Percentage of HTN and DM patients who quit smokingQuit smoking is defined as not having smoked, even 1 or 2 puffs, during the past 6 monthsCommunity surveysTobacco Use Questionnaire0, 12, 24
Percentage of HTN and DM patients who met the recommended PAe level≥150 minutes MVPA f per weekCommunity surveysWHO STEPSg0, 12, 24
Reach
Percentage of adults with HTN screened for HTNHad a BP measurement in past 12 monthsCommunity surveysQuestionnaire0, 12, 24
Percentage of adults with DM screened for DMHad a BGh measurement in past 12 monthsCommunity surveysQuestionnaire0, 12, 24
Percentage of patients with HTN and DM receiving treatment from public PHCi facilitiesCurrently receiving care from government PHC facilitiesCommunity surveysQuestionnaire0, 12, 24
Adoption
Percentage of patients with HTN and DM registered in the Simple appInformation recorded in the Simple app, separated for CCj and NCDk cornerSimple appSimple appQuarterly
Percentage of CCs who conducted NCD screeningScreening ≥50 adults/monthSimple appSimple appQuarterly
Percentage of CCs who performed routine care for patients with NCDFollowing up with ≥25 patients/monthSimple appSimple appQuarterly
Percentage of CHWsl who conducted home visitsHome visits for ≥5 patients/month for lifestyle counseling and adherence supportCHW reportCHW reportQuarterly
Implementation
Percentage of providers who participated in training and refresherParticipated in training on NCD managementTraining reportTraining registryBiannually
Percentage of CCs with functional essential equipment and supplyBP/BG machines are calibrated, strips, and IECm materials availableFacility recordsFacility reportQuarterly
Percentage of planned supportive supervision conducted8 planned supervisions, separated by levels of PHC and CHWSupervision reportChecklistQuarterly
Maintenance
Percentage of newly enrolled patients retained in careLTFUn: ≥3 months late for the last scheduled visit, 6/12 monthsPatient registryPatient registry12, 24, 30
CCs who performed routine care for NCD patientsFollowing up with ≥25 patients/monthPatient registryPatient registry30
NCD corner that used the Simple app for patient management≥80% patient encounters recorded in the Simple appPatient registryPatient registry30

aRE-AIM: reach, effectiveness, adoption, implementation, and maintenance framework.

bHTN: hypertension.

cBP: blood pressure.

dDM: diabetes mellitus.

ePA: physical activity.

fMVPA: moderate to vigorous physical activity.

gWHO STEPS: World Health Organization’s STEPwise approach to NCD risk factor surveillance.

hBG: blood glucose.

iPHC: primary health care.

jCC: community clinic.

kNCD: noncommunicable disease.

lCHW: community health worker.

mIEC: information, education, and communication.

nLTFU: lost to follow-up.

Figure 3. Program theory. (A)HI: assistant health inspector; BG: blood glucose; BP: blood pressure; CC: community clinic; CHCP: community health care provider; CHW: community health worker; FU: follow-up; HCP: health care provider; IEC: information, education, communication; NCD: noncommunicable disease; PPP: public-private partnership; SAC: stakeholder advisory committee; SES: socioeconomic status; Tx: treatment.

We anticipated some minor practical refinements and adaptations of the intervention components during the implementation process. Any refinements and the rationale for these are being documented for transparent reporting, guided by the program theory and updated MRC guidance.

For specific aim 3, the primary cost-effectiveness measure is the incremental cost per 1-percentage-point increase in the proportion of participants achieving control status over the 24-month intervention period. Detailed costs by input categories and steps in intervention components will be estimated. Both health system costs and patient costs will be compared between the intervention and usual care arms.

Sampling Strategy and Power Calculation

Three community-based surveys are undertaken at months 0, 12, and 24. For each evaluation survey, an independent random sample of adults aged 40 years and above who are community residents in 3 study subdistricts is randomly selected through a multistage cluster sampling approach. We opted for a quasi-experimental design with repeated cross-sectional surveys, instead of a traditional randomized trial, to capture changes in the entire care continuum at the population level and to generate real-world evidence on effectiveness and implementation strategies for greater external validity [58,59]. A buffer zone between the 2 intervention subdistricts (ie, Chirirbandar and Parbatipur) was created to mitigate potential spillover effects between contiguous communities. Given the available resources and time constraints, we randomly select a total of 15 villages from each subdistrict. The villages are divided into segments of approximately 250 households without disrupting the boundaries of the villages. One segment per village is then randomly selected. Subsequently, a list of adults aged 40 years of age within each village of the selected segment is obtained. From each segment (cluster), an equal number of women and men ≥40 years of age are randomly selected by using systematic random sampling with the condition that no more than 1 adult male and 1 adult female is included from the same household.

The planned sample size was determined to be 6750 participants for each community survey, with an equal number of clusters per subdistrict (15 clusters per subdistrict, or 45 clusters total) and similar cluster sizes (150 participants: 75 females and 75 males per cluster). Assuming a prevalence of diagnosed hypertension of 40%, and 15% for diabetes among adults aged 40 years and above, based on South Asia Biobank [60] data (unpublished findings), we expected to collect information from 2700 individuals with hypertension and 1000 individuals with diabetes. Assuming a conservative intraclass correlation coefficient of 0.02 [25,61], and a 2-sided type I error rate of 5%, the survey has 80% power to detect a difference as small as 7 percentage points between the intervention and reference groups for BP control, and a 10 percentage point difference for glycemic control. Power calculations were performed using Stata 17 (Stata Inc.) power analysis for a clustered 2-sample proportions test [62]. The planned sample size for binary outcomes ensures sufficient power for continuous specifications of the outcomes [25,61,63].

Data Collection, Management, Quality, and Security

Baseline community surveys used interviewer-administered questionnaires and physical examinations. The baseline questionnaire, an adapted version of the WHO STEPS (World Health Organization’s STEPwise approach to NCD risk factor surveillance) questionnaire, covers sociodemographic characteristics, comorbidities, medication use, and health behaviors. The questionnaire was translated into Bengali and piloted for clarity and digitized using Kobo Toolbox for data collection. BP was measured by research staff using Omron HEM-7120. Capillary BG after at least 8 hours of fasting was measured using Accu-Chek Instant (Roche Diabetes Care).

Facility-based data collection is being conducted via the Simple app by on-site staff. Demographic and NCD history, medication use, BP/BG measurements, and treatment dosages are being recorded. In usual care subdistricts, the same data are being collected through patient registry reviews. Additional facility-level data, such as medication availability, device functionality, and treatment success rates, are being collected for process evaluation. An acceptability and utility survey of the Simple app for NCD management will be administered to health care providers in intervention subdistricts at months 12 and 24. All providers involved in hypertension or diabetes care at NCD corners and CCs will be invited to participate.

All health care providers in primary care facilities who are directly involved in NCD care were approached for qualitative data collection at baseline. This included 15 doctors and nurses from 3 subdistrict NCD corners and 15 CHCPs from CCs. Additionally, 6 public health officials (2 from each subdistrict) were approached for an in-depth interview (IDI). Furthermore, 9 focus group discussions (FGDs) with patients living with hypertension, diabetes, or both conditions were conducted. For each FGD, 8‐12 patients were included. Participants were purposively selected to maximize the diversity of the sample on sociodemographic characteristics (eg, age, sex, religion, socioeconomic status, and geographic distance to health facilities) and NCD history (new and experienced). Qualitative data collection will be repeated by the end of the study with the same group of public health officials and NCD care providers. In cases of staff turnover, the ones who are in position at the time of data collection will be approached. Patient FGDs will be repeated with the same groups of participants. Moreover, all 15 CHWs will be approached for an FGD session. FGD/IDI guides were developed based on the WHO’s 7-domain framework of health care delivery [64], chronic care model [10], and prespecified program theory. Interviews will be audio-recorded and are expected to each take 30‐45 minutes to complete. Qualitative data collection will be performed at baseline and endline surveys.

The qualitative data collected from health administrators, clinicians, and CHWs in intervention subdistricts provide qualitative insights on barriers and facilitators to NCD care delivery, experiences with the Simple app, study participation, workflow restructuring, and teamwork with clinics and CHWs. Data collection at endline allows participants to reflect on changes in these aspects over time. Patient FGDs explore barriers and facilitators to care accessibility and perceptions of care quality, including specific intervention components like drug refills, CHW home visits, and CHCP follow-ups.

Hypertension- and diabetes-related treatment costs were collected for economic evaluation, including direct and indirect costs (eg, transportation, food, childcare, and lost work time) at baseline. Health service delivery costs, including staff, transportation, laboratory, training, utilities, and overheads, are being assessed using microcosting to track time and resources spent on activities [65]. Intervention costs account for the setting, target population, resources, and consumables such as medical supplies and overheads.

To protect privacy and ensure confidentiality of data being collected, identifying information associated with the study participants is being kept confidential through unique identifying numbers on all paper forms and computer-based files. This file linking names and study numbers is password-protected, only accessible to authorized study personnel. All electronic data are encrypted, password protected, and stored in secure computer networks. All study personnel were trained to follow standard protocols.

Adverse Event Monitoring

Serious adverse events, including death, hospitalization, and other conditions that result in persistent or significant disability, were handled by medical professionals at the subdistrict NCD corner as per standard protocol. Health care providers at CC were required to send patients back to the subdistrict NCD corner for evaluation when persistent poor control of BP and BG is observed among patients managed at CCs. Adverse events were recorded by study personnel.

Statistical Analysis Plan

Baseline characteristics of participants, including sociodemographic characteristics, medical history, anthropometrics, and lifestyle factors, will be compared between the 2 intervention and 1 control subdistricts using 1-way ANOVA or Rao-Scott χ2 tests. Analyses will be stratified by hypertension and diabetes status. A difference-in-difference estimate for hypertension and diabetes will be implemented with multivariate logistic regression analyses, which take the following form:

log(p/1p)=β0+β1 Time +β2 Intervention +β3 [TimeIntervention]+β4 Covariates+ε

The β3 coefficient captures the difference in change over time. Clustered standard errors at the village segment level will be specified to allow for intragroup correlation, relaxing the usual requirement that the observations within a cluster are independent [66]. Several individual- and area-level covariates (β4) will be included in the analytic models to mitigate confounding by potential different sample composition. These covariates will include age, sex, education, wealth, tobacco use, physical activity, self-reported fruit and vegetable intake, self-reported history of chronic disease (eg, CVD, chronic respiratory disease, cancer, and chronic kidney disease), and rural or urban status. Given that the evaluation follows a multistage process whereby village segment clusters are randomly sampled from each subdistrict, and individuals are sampled randomly from the village segment clusters, a clustering adjustment for standard error is necessary to avoid inflating the precision of the estimated intervention effect [67,68]. Marginal effects will be calculated to illustrate how the predicted probability (ie, the proportion of patients with controlled conditions) changes over time among the three groups. Potential heterogeneity of effects will be explored in subgroup analyses, defined by age, sex, religion, and socioeconomic status. Several sensitivity analyses will be performed to check the robustness of the findings to critical model assumptions and missing data. While the “parallel” assumption should be tested with repeated measures prior to the intervention, this was not feasible given the budget and other limitations. Instead, we are testing the assumption with a negative control in treatment or outcome. Second, we will test the robustness of the results to different modeling approaches to handle geographical clustering of participants and over time. Third, missing data patterns and potential mechanisms (ie, whether missing at random can be assumed) will be assessed. If missing data only affect a small proportion (ie, <5%) of the sample, listwise deletion will be done; otherwise, missing data will be handled with multiple imputation with chained equations if missing at random assumption is reasonable.

The facility-based cohort data collected longitudinally will capture patients’ treatment trajectory over the study period. Changes in the proportion of patients with a controlled condition will be analyzed with generalized estimating equation Poisson regression with robust variance [69,70]. Continuous changes in systolic BP and diastolic BP from baseline will be assessed with linear mixed effects models.

For qualitative data, dual Bengali-English language speakers on the study team will transcribe and translate the audio-recorded IDIs and FGDs into English. The English language version of the transcripts will then be coded and analyzed thematically using NVivo, a qualitative data software program developed by Lumivero. Qualitative data will allow the identification of specific barriers to and facilitators of interventions by exploring the experiences of patients and clinicians engaged in different models of NCD care delivery. Qualitative data analysis will be guided by prespecified program theory, the RE-AIM framework, and standard grounded theory to identify themes, build and apply codebooks, and describe thematic characteristics, patterns, and relationships [71,72].

For the economic evaluation, we will compare the costs and effects of intervention with the usual care group, both from financial and economic perspectives [73]. Financial cost per unit outcome will be calculated by dividing the total cost by the quantifiable unit of outcome (screening, treatment, retention in care, and control) for each of the three groups. Incremental cost-effectiveness ratios (ICERs) will be computed to compare the additional costs and effects of each intervention with the usual care. A nonparametric bootstrap with 1000 replications will be used to estimate 95% CIs around the point estimate of ICERs. All local currency (Bangladeshi Taka) costs will be converted to US dollars using the prevailing exchange rates and will be adjusted for inflation rates, discounted at 3%, and expressed in the 2025 US dollar present value terms. Sensitivity analysis will explore the robustness of the results to alternative probability distributions, time horizon, and uncertainty of key variables.

Descriptive statistics were reported for baseline characteristics of the sample stratified by subdistricts. Percentage estimates for key primary and secondary outcomes were age-standardized to the 2023 Bangladeshi population using age groups 40‐49, 50‐59, and ≥60 years, derived from the United Nations’ Population Division of the Department of Economic and Social Affairs World Population Prospects. We used a direct standardization approach using the STDIZE and STDWEIGHT Stata commands. The preliminary analyses were performed using Stata 18.0 (StataCorp Inc).

Stakeholder Engagement

To ensure that the strategies developed are feasible, contextually appropriate, and sustainable in real-world settings, stakeholder groups (including government agencies, health care providers, and community representatives) have been actively engaged to enable cocreation. At the study design phase, input from relevant government agencies, major nongovernmental organizations, and community representatives was sought. During implementation, monthly meetings with subdistrict-level public health officials and CHWs were convened to facilitate bidirectional exchange of knowledge. As a member of the Bangladesh national committee for the revision of the national hypertension and diabetes protocol, the site principal investigator has shared findings with national policymakers. A stakeholder advisory group has been convened, with its first annual meeting planned for the end of 2025.


A baseline community survey was conducted between January and March 2024. The baseline data consist of a sample of 6849 adults aged 40 years and above randomly selected from 45 villages from 3 subdistricts (Biral, Parbatipur, and Chirirbandar) in Dinajpur district. Exclusion criteria included pregnancy, adults with terminal illness who have difficulty completing the survey or taking anthropometric measurements and physical examinations, and people who are unable to give consent. The sample was drawn with a 3-stage cluster sampling scheme. The first stage included a selection of 45 villages, which were selected stratified by subdistrict and proportional to population size. Stage 2 included the selection of one segment from each village, with each segment consisting of ~250 households. Household listing was done to create a sampling frame of male and female adults aged 40 years and above currently residing in the selected villages. A simple random sample of 88 male adults and 88 female adults was selected with the condition that not more than 1 male or female could be selected from the same household. The response rate was 86%.

The social and demographic characteristics of participants involved in the baseline survey are presented in Table 3. Overall, the mean age of the participants was 55.9 (SD 10.6) years; almost exactly 50.1% (3432/6849) were female. Forty percent of participants (2704/6849) had no formal schooling, and only 12.1% (829/6849) had secondary or higher education. The majority (6316/6849, 92.2%) of the sample was self-employed or worked as a homemaker. The majority of the sample was Muslim (5313/6849, 77.6%) and was currently married (5932/6849, 86.6%). Other than religion, employment, and wealth score, there was no statistical difference among the 3 subdistricts (arms) based on these sociodemographic characteristics.

Table 3. Sample characteristics of baseline community survey.
VariablesTotalComparison groups
Usual careDigital onlyMulticomponentP value
Participants, n (%)6849 (100)2262 (33.0)2287 (33.6)2300 (33.4)
Age in years, mean (SD)55.9 (10.6)56.0 (10.4)56.1 (10.9)55.7 (10.6).37
Sex, n (%).96
Male3417 (49.9)1134 (50.1)1143 (49.7)1140 (49.8)
Female3432 (50.1)1128 (49.9)1157 (50.3)1147 (50.2)
Education attainment, n (%).73
No formal schooling2704 (39.5)916 (40.5)897 (39.0)891 (39.0)
Primary3319 (48.4)1075 (47.5)1116 (48.5)1125 (49.2)
Secondary or higher829 (12.1)271 (12.0)287 (12.5)271 (11.8)
Marital status, n (%).58
Currently married5932 (86.6)1954 (86.4)1983 (86.2)1995 (87.2)
Widowed or other917 (13.4)308 (13.6)317 (13.8)292 (12.8)
Religion, n (%)<.001
Muslim5313 (77.6)1741 (77.0)1868 (81.2)1704 (74.5)
Non-Muslim1536 (22.4)521 (23.0)432 (18.8)583 (25.5)
Employment, n (%)<.001
Employed or retired212 (3.1)69 (3.1)72 (3.1)71 (3.1)
Self-employed or homemaker6316 (92.2)2093 (92.5)2082 (90.6)2141 (93.6)
Unemployed319 (4.7)100 (4.1)144 (6.3)75 (3.3)
Wealth score, n (%).004
Low2261 (33.0)736 (32.5)761 (33.1)764 (33.4)
Medium2270 (33.1)703 (31.1)768 (33.4)799 (34.9)
High2318 (33.8)823 (36.4)771 (33.5)724 (31.7)
BMI (kg/m2) category, n (%).30
<18.5911 (13.3)306 (13.5)321 (14.0)284 (12.4)
18.5‐22.93067 (44.8)1041 (46.0)1024 (44.5)1002 (43.8)
23.0‐27.42185 (31.9)701 (31.0)731 (31.8)753 (32.9)
≥27.5686 (10.0)214 (9.5)224 (9.7)248 (10.8)
Elevated WCa, n (%)2583 (37.7)827 (36.6)878 (38.2)878 (38.4).45
Mental healthb, n (%)
Depression666 (9.7)252 (11.1)191 (8.3)223 (9.8).005
Anxiety361 (5.3)161 (7.1)80 (3.5)120 (5.2)<.001
Family history, n (%)
Premature CVDc702 (10.2)249 (11.0)252 (11.0)201 (8.8).02
Diabetes1155 (16.9)399 (17.6)355 (15.4)401 (17.5).09
Self-reported medical history, n (%)
CVD202 (2.9)54 (2.4)70 (3.0)78 (3.4).12
COPDd/asthma307 (4.5)111 (4.9)125 (5.4)71 (3.1)<.001
Other NCDe231 (3.4)75 (3.3)74 (3.2)82 (3.6).76
Hypertension, n (%)2690 (39.3)876 (38.7)959 (41.7)855 (37.4).01
Diabetes, n (%)967 (14.1)329 (14.5)298 (13.0)340 (14.9).14

aWC: waist circumference.

bDepression and anxiety were assessed using PHQ-2 and GAD-2, respectively, with a cutoff point of ≥3 as indicating these mental health symptoms.

cCVD: cardiovascular disease.

dCOPD: chronic obstructive pulmonary disease.

eNCD: noncommunicable disease.

Among all participants, the prevalence of hypertension, diabetes, overweight and obesity, and self-reported CVD were 39.3% (2690/6849), 14.1% (967/6849), 41.9% (2871/6849), and 2.9% (202/6849), respectively. Ten percent (702/6849) of the participants had a family history of premature CVD, and 16.9% (1155/6849) had a family history of diabetes. Across the 3 arms (subdistricts), the digital intervention arm appeared to have a higher prevalence of hypertension compared with the multicomponent and the usual care arms (855/2300, 41.7%; 959/2287, 37.4%; and 876/2262, 38.7%; respectively).

The baseline age-standardized BP control rate among participants with hypertension was 10.2%, while baseline glycemic control among participants with diabetes was 14.9% (Table 4). There were slight differences across the 3 subdistricts. For secondary outcomes, age-standardized awareness and treatment rates for hypertension were 35.3% and 23.0%, respectively, and 60.7% and 33.9% for diabetes, respectively. Among participants living with hypertension, diabetes, or both conditions, 47.1% met the physical activity level recommended by WHO, and 48.5% had quit smoking.

Table 4. Outcome measures at baseline.a
OutcomesTotal, n (%)Comparison groups, n (%)
Usual careDigital onlyMulticomponentP value
Primary outcomes
 Achieved blood pressure controlb263 (10.2)67 (8.5)80 (8.8)116 (13.4).003
 Achieved glycemic controlc154 (14.9)72 (20.0)36 (11.0)46 (13.5).001
Secondary outcomes
 Awareness of hypertension statusb942 (35.3)287 (33.4)324 (34.2)331 (38.6).06
 On treatment for hypertensionb635 (23.0)166 (19.1)212 (21.3)257 (29.0)<.001
 Awareness of diabetes statusc591 (60.7)215 (65.3)169 (56.5)207 (60.2).09
 On treatment for diabetes334 (33.9)96 (27.3)105 (34.5)133 (39.1).03
 Patients with hypertension/diabetes who met physical activity targetd1461 (47.1)469 (45.9)441 (41.2)551 (54.6)<.001
 Patients with hypertension/diabetes who quit smokinge579 (48.5)189 (48.2)205 (52.7)185 (45.4).05

aPercentage estimates are age-standardized to the 2023 Bangladeshi population using age groups 40‐49, 50‐59, and ≥60 years, derived from the United Nations’ Population Division of the Department of Economic and Social Affairs World Population Prospects.

bThe number of participants with hypertension was 2690 overall (867, 959, and 855 for usual care, digital-only, and multicomponent arms, respectively).

cThe number of participants with diabetes was 967 overall (329, 298, and 340 for usual care, digital-only, and multicomponent arms, respectively).

dThe number of participants with hypertension, diabetes, or both conditions was 3137 overall (1021, 1101, and 1015 for usual care, digital-only, and multicomponent arms, respectively).

eThe number of participants with hypertension, diabetes, or both conditions who ever smoked was 957 overall (328, 309, and 320 for usual care, digital-only, and multicomponent arms, respectively).


Driven by population aging, rapid urbanization, and the globalization of unhealthy lifestyles, the burden of NCDs is rapidly increasing in LMICs [2,74,75]. However, access to quality care remains limited in LMICs, particularly in rural areas. Awareness, diagnosis, treatment, and control rates of hypertension and diabetes are low. Strengthening primary care to address NCDs requires novel approaches to address complex barriers at the health system, provider, and patient levels [12]. Several features of NCDs, including shared lifestyle risk factors, comorbidity, and chronicity, necessitate a shifting of care organization from episodic care toward a long-term integrated approach to prevention, diagnosis, and treatment across overlapping conditions [12]. A well-coordinated team-based model of care is critical for the care continuity necessary to achieve sustained control of chronic conditions [29,76]. Digital technologies offer the potential to tackle health system challenges in LMICs, improve access to and quality of health care, and reduce health system costs [77]. The emergence of the COVID-19 pandemic has intensified the need for digital technologies to support decentralized NCD care [78,79]. However, few digital interventions have demonstrated effectiveness in NCD care [28,30,80]. Progress toward successful implementation and scaling up of digital innovations for primary care delivery in LMIC settings remains limited and requires collaborative research and development efforts between health system stakeholders and technology communities to address holistically.

This study is among the first to evaluate the effectiveness, cost-effectiveness, and implementation strategy of a digital technology-supported decentralized primary care model for integrated hypertension and diabetes management in an LMIC context [24,25]. With a combination of repeated cross-sectional community surveys, routinely collected facility-based longitudinal data, qualitative data collection, and a cost-effectiveness evaluation, this study is expected to provide rich implementation and effectiveness data on a multicomponent digital technology-supported decentralized intervention for integrated hypertension and diabetes care. The findings from the study will provide valuable insights for the Simple app developers and the larger global health technology community, supporting their efforts to develop effective digital solutions to address NCD challenges.

The baseline community survey has been completed with a high response rate and excellent data completion rates. At the time of writing this paper, initial training of health care providers and managers has been completed, the Simple app has been successfully deployed, and CCs have been equipped to provide hypertension and diabetes screening, referral, and management. Facility-based data collection has been set up. Data analysis on the baseline community survey and facility-based survey is ongoing. Stakeholders have been actively engaged, and initial findings have been shared with relevant government agencies.

Designed to generate rich process and implementation data, the study is limited in the number of primary care facilities involved and geographical representativeness. Thus, the results will need to be interpreted in relation to the specific regional socioeconomic context. Nevertheless, our implementation assessment results will shed light on the transportability of the interventions in different contexts, which might include density of primary facilities, density and information technology knowledge of health care providers, availability of CHWs, internet connection, etc. Furthermore, unlike a randomized controlled trial, the quasi-experimental approach relies on a strong “common trends” assumption to establish a counterfactual. Without randomization, causal inferences are difficult to establish. Nevertheless, we have collected extensive data on potential confounding variables and planned extensive sensitivity analyses to evaluate potential biases as previously discussed.

As the government of Bangladesh is taking more steps to mitigate the increasing burden of NCDs and to achieve the Sustainable Development Goals, the evidence generated from the proposed study will be directly relevant for policymaking and programmatic efforts for NCD prevention and management in Bangladesh. The implementation and cost-effectiveness data may be particularly important to inform the scalability and sustainability of the interventions. The findings will likely be internationally relevant, as many LMICs share similar challenges as Bangladesh regarding NCD prevention and control.

Funding

This research was funded by the UK National Institute for Health Research (NIHR) (16/136/68 and 132960) using UK aid from the UK Government to support global health research. The views expressed in this publication are those of the authors and not necessarily those of the NIHR or the UK Department of Health and Social Care.

Authors' Contributions

JC, MKM, and BO conceived the study. JC, MKM, BO, and WX designed the initial study protocol. WX wrote the initial draft of the manuscript, and all the authors were involved in preparing this manuscript and contributed to the revision of the manuscript. JC acquired funding. MKM and JC supervised the implementation of the study. JC is the co-corresponding author and can be reached via email at john.chambers@imperial.ac.uk.

Conflicts of Interest

None declared.

  1. Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. Jan 2022;183:109119. [CrossRef] [Medline]
  2. Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019. J Am Coll Cardiol. Dec 2020;76(25):2982-3021. [CrossRef]
  3. Zhou B, Bentham J, Di Cesare M, et al. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet. Jan 2017;389(10064):37-55. [CrossRef]
  4. Zhou B, Carrillo-Larco RM, Danaei G, et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. Sep 2021;398(10304):957-980. [CrossRef]
  5. Gu Q, Dillon CF, Burt VL, Gillum RF. Association of hypertension treatment and control with all-cause and cardiovascular disease mortality among US adults with hypertension. Am J Hypertens. Jan 2010;23(1):38-45. [CrossRef] [Medline]
  6. Zhou D, Xi B, Zhao M, Wang L, Veeranki SP. Uncontrolled hypertension increases risk of all-cause and cardiovascular disease mortality in US adults: the NHANES III Linked Mortality Study. Sci Rep. Jun 20, 2018;8(1):9418. [CrossRef] [Medline]
  7. Manne-Goehler J, Geldsetzer P, Agoudavi K, et al. Health system performance for people with diabetes in 28 low- and middle-income countries: a cross-sectional study of nationally representative surveys. PLoS Med. Mar 2019;16(3):e1002751. [CrossRef] [Medline]
  8. Geldsetzer P, Manne-Goehler J, Marcus ME, et al. The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1·1 million adults. Lancet. Aug 2019;394(10199):652-662. [CrossRef]
  9. Zhou B, Perel P, Mensah GA, Ezzati M. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat Rev Cardiol. Nov 2021;18(11):785-802. [CrossRef] [Medline]
  10. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, Part 2. JAMA. Oct 16, 2002;288(15):1909-1914. [CrossRef] [Medline]
  11. Kabir A, Karim MN, Islam RM, Romero L, Billah B. Health system readiness for non-communicable diseases at the primary care level: a systematic review. BMJ Open. Feb 2022;12(2):e060387. [CrossRef]
  12. Kruk ME, Nigenda G, Knaul FM. Redesigning primary care to tackle the global epidemic of noncommunicable disease. Am J Public Health. Mar 2015;105(3):431-437. [CrossRef]
  13. Kruk ME, Gage AD, Arsenault C, et al. High-quality health systems in the Sustainable Development Goals era: time for a revolution. Lancet Glob Health. Nov 2018;6(11):e1196-e1252. [CrossRef]
  14. Global report on hypertension: the race against a silent killer. World Health Organization; Sep 19, 2023. URL: https://www.who.int/publications/i/item/9789240081062 [Accessed 2025-12-12]
  15. Chowdhury HA, Paromita P, Mayaboti CA, et al. Assessing service availability and readiness of healthcare facilities to manage diabetes mellitus in Bangladesh: findings from a nationwide survey. PLoS One. 2022;17(2):e0263259. [CrossRef] [Medline]
  16. Islam K, Huque R, Saif-Ur-Rahman KM, Ehtesham Kabir ANM, Enayet Hussain AHM. Implementation status of non-communicable disease control program at primary health care level in Bangladesh: findings from a qualitative research. Public Health Pract (Oxf). Jun 2022;3:100271. [CrossRef] [Medline]
  17. Correia JC, Lachat S, Lagger G, et al. Interventions targeting hypertension and diabetes mellitus at community and primary healthcare level in low- and middle-income countries: a scoping review. BMC Public Health. Nov 21, 2019;19(1):1542. [CrossRef] [Medline]
  18. Ye J, Orji I, Baldridge AS, et al. Characteristics and patterns of retention in hypertension care in primary care settings from the Hypertension Treatment in Nigeria Program. Circulation. Mar 2022;145(Suppl_1):e2230025. [CrossRef]
  19. Labhardt ND, Balo JR, Ndam M, Grimm JJ, Manga E. Task shifting to non-physician clinicians for integrated management of hypertension and diabetes in rural Cameroon: a programme assessment at two years. BMC Health Serv Res. Dec 14, 2010;10(1):1-10. [CrossRef] [Medline]
  20. Deo S, Singh P. Community health worker-led, technology-enabled private sector intervention for diabetes and hypertension management among urban poor: a retrospective cohort study from large Indian metropolitan city. BMJ Open. Aug 12, 2021;11(8):e045246. [CrossRef] [Medline]
  21. Brennan AT, Long L, Maskew M, et al. Outcomes of stable HIV-positive patients down-referred from a doctor-managed antiretroviral therapy clinic to a nurse-managed primary health clinic for monitoring and treatment. AIDS. Oct 23, 2011;25(16):2027-2036. [CrossRef] [Medline]
  22. Sanne I, Orrell C, Fox MP, et al. Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial. Lancet. Jul 2010;376(9734):33-40. [CrossRef]
  23. Lehmann U, Van Damme W, Barten F, Sanders D. Task shifting: the answer to the human resources crisis in Africa? Hum Resour Health. Jun 21, 2009;7(1):1-4. [CrossRef] [Medline]
  24. Kaur P, Kunwar A, Sharma M, et al. The India Hypertension Control Initiative—early outcomes in 26 districts across five states of India, 2018-2020. J Hum Hypertens. Jul 2023;37(7):560-567. [CrossRef] [Medline]
  25. Patel SA, Sharma H, Mohan S, et al. The Integrated Tracking, Referral, and Electronic Decision Support, and Care Coordination (I-TREC) program: scalable strategies for the management of hypertension and diabetes within the government healthcare system of India. BMC Health Serv Res. Nov 9, 2020;20(1):1022. [CrossRef] [Medline]
  26. Xie W, Paul RR, Goon IY, et al. Enhancing care quality and accessibility through digital technology-supported decentralisation of hypertension and diabetes management: a proof-of-concept study in rural Bangladesh. BMJ Open. Nov 2023;13(11):e073743. [CrossRef]
  27. Anchala R, Kaptoge S, Pant H, Di Angelantonio E, Franco OH, Prabhakaran D. Evaluation of effectiveness and cost-effectiveness of a clinical decision support system in managing hypertension in resource constrained primary health care settings: results from a cluster randomized trial. J Am Heart Assoc. Jan 5, 2015;4(1):e001213. [CrossRef] [Medline]
  28. Prabhakaran D, Jha D, Prieto-Merino D, et al. Effectiveness of an mHealth-based electronic decision support system for integrated management of chronic conditions in primary care. Circulation. Jan 15, 2019;139(3):380-391. [CrossRef]
  29. Kumar A, Schwarz D, Acharya B, et al. Designing and implementing an integrated non-communicable disease primary care intervention in rural Nepal. BMJ Glob Health. 2019;4(2):e001343. [CrossRef] [Medline]
  30. Xiong S, Lu H, Peoples N, et al. Digital health interventions for non-communicable disease management in primary health care in low- and middle-income countries. NPJ Digit Med. Feb 1, 2023;6(1):12. [CrossRef] [Medline]
  31. He J, Irazola V, Mills KT, et al. Effect of a community health worker-led multicomponent intervention on blood pressure control in low-income patients in Argentina: a randomized clinical trial. JAMA. Sep 19, 2017;318(11):1016-1025. [CrossRef] [Medline]
  32. Jafar TH, Gandhi M, de Silva HA, et al. A community-based intervention for managing hypertension in rural South Asia. N Engl J Med. Feb 20, 2020;382(8):717-726. [CrossRef]
  33. Schwalm JD, McCready T, Lopez-Jaramillo P, et al. A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trial. Lancet. Oct 2019;394(10205):1231-1242. [CrossRef]
  34. Joshi R, Alim M, Kengne AP, et al. Task shifting for non-communicable disease management in low and middle income countries – a systematic review. PLoS One. 2014;9(8):e103754. [CrossRef]
  35. Jeet G, Thakur JS, Prinja S, Singh M. Community health workers for non-communicable diseases prevention and control in developing countries: evidence and implications. PLoS One. 2017;12(7):e0180640. [CrossRef]
  36. Simple. URL: https://www.simple.org/ [Accessed 2025-12-15]
  37. Burka D, Gupta R, Moran AE, et al. Keep it simple: designing a user-centred digital information system to support chronic disease management in low/middle-income countries. BMJ Health Care Inform. Jan 2023;30(1):e100641. [CrossRef] [Medline]
  38. Ganeshkumar P, Bhatnagar A, Burka D, et al. Discovery, development, and deployment of a user-centered point-of-care digital information system to treat and track hypertension and diabetes patients under India Hypertension Control Initiative 2019-2022, India. Digit Health. 2024;10. [CrossRef] [Medline]
  39. Burnier M, Egan BM. Adherence in hypertension: a review of prevalence, risk factors, impact, and management. Circ Res. 2019;124(7):1124-1140. [CrossRef]
  40. Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. Oct 2020;396(10258):1204-1222. [CrossRef]
  41. Khan M, Oldroyd JC, Chowdhury EK, et al. Prevalence, awareness, treatment, and control of hypertension in Bangladesh: findings from National Demographic and Health Survey, 2017-2018. J Clin Hypertens. Oct 2021;23(10):1830-1842. [CrossRef]
  42. Khan M, Oldroyd JC, Hossain MB, Islam RM. Awareness, treatment, and control of diabetes in Bangladesh: evidence from the Bangladesh Demographic and Health Survey 2017/18. Vol 2022. 2022:8349160. [CrossRef]
  43. Riaz BK, Islam MZ, Islam A, et al. Risk factors for non-communicable diseases in Bangladesh: findings of the population-based cross-sectional national survey 2018. BMJ Open. Nov 27, 2020;10(11):e041334. [CrossRef] [Medline]
  44. Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. Mar 2012;50(3):217-226. [CrossRef] [Medline]
  45. Population and Housing Census [Web page in Bangla]. Bangladesh Bureau of Statistics. 2011. URL: https://bbs.gov.bd/pages/static-pages/6922e0ff933eb65569e297dc [Accessed 2023-11-10]
  46. Facility registry. Directorate General of Health Services. URL: https://hrm.dghs.gov.bd/public/facility-registry [Accessed 2023-11-10]
  47. Schwalm JD, McKee M, Huffman MD, Yusuf S. Resource effective strategies to prevent and treat cardiovascular disease. Circulation. Feb 23, 2016;133(8):742-755. [CrossRef] [Medline]
  48. Naheed A, Haldane V, Jafar TH, Chakma N, Legido-Quigley H. Patient pathways and perceptions of hypertension treatment, management, and control in rural Bangladesh: a qualitative study. Patient Prefer Adherence. 2018;12:1437-1449. [CrossRef] [Medline]
  49. Legido-Quigley H, Naheed A, de Silva HA, et al. Patients’ experiences on accessing health care services for management of hypertension in rural Bangladesh, Pakistan and Sri Lanka: a qualitative study. PLoS One. 2019;14(1):e0211100. [CrossRef]
  50. Nam S, Chesla C, Stotts NA, Kroon L, Janson SL. Barriers to diabetes management: patient and provider factors. Diabetes Res Clin Pract. Jul 2011;93(1):1-9. [CrossRef] [Medline]
  51. Skivington K, Matthews L, Simpson SA, et al. A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. BMJ. Sep 30, 2021;374:n2061. [CrossRef] [Medline]
  52. Abrahams-Gessel S, Denman CA, Montano CM, et al. The training and fieldwork experiences of community health workers conducting population-based, noninvasive screening for CVD in LMIC. Glob Heart. 2015;10(1):45-54. [CrossRef]
  53. Alaofè H, Asaolu I, Ehiri J, et al. Community health workers in diabetes prevention and management in developing countries. Ann Glob Health. 2017;83(3-4):661-675. [CrossRef] [Medline]
  54. Anand TN, Joseph LM, Geetha AV, Prabhakaran D, Jeemon P. Task sharing with non-physician health-care workers for management of blood pressure in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Glob Health. Jun 2019;7(6):e761-e771. [CrossRef]
  55. Schwarz D, Dhungana S, Kumar A, et al. An integrated intervention for chronic care management in rural Nepal: protocol of a type 2 hybrid effectiveness-implementation study. Trials. Jan 29, 2020;21(1):119. [CrossRef] [Medline]
  56. Moore GF, Audrey S, Barker M, et al. Process evaluation of complex interventions: Medical Research Council guidance. BMJ. Mar 19, 2015;350:h1258. [CrossRef] [Medline]
  57. Noncommunicable disease facility-based monitoring guidance: framework, indicators, and application. World Health Organization; Nov 11, 2022. URL: https://www.who.int/publications/i/item/9789240057067 [Accessed 2025-12-12]
  58. Xia T, Zhao F, Nianogo RA. Interventions in hypertension: systematic review and meta-analysis of natural and quasi-experiments. Clin Hypertens. May 1, 2022;28(1):13. [CrossRef] [Medline]
  59. Miller CJ, Smith SN, Pugatch M. Experimental and quasi-experimental designs in implementation research. Psychiatry Res. Jan 2020;283:112452. [CrossRef] [Medline]
  60. Song P, Gupta A, Goon IY, et al. Data resource profile: understanding the patterns and determinants of health in South Asians—the South Asia Biobank. Int J Epidemiol. Jul 9, 2021;50(3):717-718e. [CrossRef] [Medline]
  61. Gandhi M, Assam PN, Turner EL, et al. Statistical analysis plan for the control of blood pressure and risk attenuation-rural Bangladesh, Pakistan, Sri Lanka (COBRA-BPS) trial: a cluster randomized trial for a multicomponent intervention versus usual care in hypertensive patients. Trials. Nov 29, 2018;19(1):658. [CrossRef] [Medline]
  62. Ahn C, Heo M, Zhang S. Sample Size Calculations for Clustered and Longitudinal Outcomes in Clinical Research. CRC Press; 2014. ISBN: 1466556269
  63. Campbell MJ, Julious SA, Altman DG. Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons. BMJ. Oct 28, 1995;311(7013):1145-1148. [CrossRef] [Medline]
  64. Monitoring the Building Blocks of Health Systems: A Handbook of Indicators and Their Measurement Strategies. World Health Organization; 2010. ISBN: 9241564059
  65. Xu X, Lazar CM, Ruger JP. Micro-costing in health and medicine: a critical appraisal. Health Econ Rev. Jan 6, 2021;11:1. [CrossRef] [Medline]
  66. White H. Maximum likelihood estimation of misspecified models. Econometrica. Jan 1982;50(1):1. [CrossRef]
  67. Bertrand M, Duflo E, Mullainathan S. How much should we trust differences-in-differences estimates? Q J Econ. Feb 1, 2004;119(1):249-275. [CrossRef]
  68. Abadie A, Athey S, Imbens GW, Wooldridge J. When should you adjust standard errors for clustering? National Bureau of Economic Research; Nov 2017. [CrossRef]
  69. Zou G, Donner A. Extension of the modified Poisson regression model to prospective studies with correlated binary data. Stat Methods Med Res. Dec 2013;22(6):661-670. [CrossRef]
  70. Yelland LN, Salter AB, Ryan P. Performance of the modified Poisson regression approach for estimating relative risks from clustered prospective data. Am J Epidemiol. Oct 15, 2011;174(8):984-992. [CrossRef] [Medline]
  71. Strauss A, Corbin J. Basics of Qualitative Research: Techniques and Procedures for Developing Grounded Theory. 2nd ed. Sage Publications; 1998.
  72. Ryan GW, Bernard HR. Techniques to identify themes. Field Methods. Feb 2003;15(1):85-109. [CrossRef]
  73. Sanders GD, Neumann PJ, Basu A, et al. Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine. JAMA. Sep 13, 2016;316(10):1093-1103. [CrossRef] [Medline]
  74. Noncommunicable diseases. World Health Organization. Sep 25, 2022. URL: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases [Accessed 2025-12-12]
  75. Bloom DE, Cafiero E, Jané-Llopis E, Abrahams-Gessel S, Bloom LR, Fathima S, et al. The global economic burden of noncommunicable diseases. World Economic Forum; Sep 2011. URL: https://www3.weforum.org/docs/WEF_Harvard_HE_GlobalEconomicBurdenNonCommunicableDiseases_2011.pdf [Accessed 2025-12-12]
  76. Starfield B. Is primary care essential? Lancet. Oct 1994;344(8930):1129-1133. [CrossRef]
  77. Labrique AB, Wadhwani C, Williams KA, et al. Best practices in scaling digital health in low and middle income countries. Global Health. Dec 2018;14(1):1-8. [CrossRef]
  78. Kluge HHP, Wickramasinghe K, Rippin HL, et al. Prevention and control of non-communicable diseases in the COVID-19 response. Lancet. May 2020;395(10238):1678-1680. [CrossRef]
  79. Reddy SK, Kunwar A, Durgad K, et al. Decentralization of India Hypertension Control Initiative services to maintain continuum of care for hypertensive patients during COVID-19 pandemic in Telangana. WHO South East Asia J Public Health. 2021;10(Suppl 1):S49-S58. [CrossRef]
  80. Peiris D, Praveen D, Mogulluru K, et al. SMARThealth India: a stepped-wedge, cluster randomised controlled trial of a community health worker managed mobile health intervention for people assessed at high cardiovascular disease risk in rural India. PLoS One. 2019;14(3):e0213708. [CrossRef]


BG: blood glucose
BP: blood pressure
CC: community clinic
CHCP: community health care provider
CHW: community health worker
CVD: cardiovascular disease
FGD: focus group discussion
ICER: incremental cost-effectiveness ratio
IDI: in-depth interview
LMIC: low- and middle-income country
MRC: UK Medical Research Council
NCD: noncommunicable disease
RE-AIM: reach, effectiveness, adoption, implementation, and maintenance framework
WHO: World Health Organization
WHO PEN: WHO Package of Essential Noncommunicable Diseases Interventions
WHO STEPS: World Health Organization’s STEPwise approach to NCD risk factor surveillance


Edited by Javad Sarvestan; submitted 17.Jul.2025; peer-reviewed by Nachiket Mor, Yun Shen; final revised version received 03.Nov.2025; accepted 19.Nov.2025; published 02.Feb.2026.

Copyright

© Wubin Xie, Sabrina Ahmed, Ali Ahsan, Ananya Gupta, Anais Masako Keenan, Tanmoy Sarker, Fahmida Akter, Aysha Anan, Md Mokbul Hossain, Zahidul Quayyum, AHM Enayet Hussain, Robed Amin, Imran Ahmed Chowdhury, Mithila Faruque, Sohel Reza Choudhury, Ian Y Goon, Fred Hersch, Lora L Sabin, Brian Oldenburg, John Chambers, Malay Kanti Mridha. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 2.Feb.2026.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on https://www.researchprotocols.org, as well as this copyright and license information must be included.